Paul van Slyke

No open positions remaining

Health Technology

Consumer Services

Profile

Paul van Slyke formerly worked at Vasomune Therapeutics, Inc., as Chief Scientific Officer, Sairiyo Therapeutics, Inc., as Chief Scientific Officer, and Pharmadrug, Inc., as Chief Scientific Officer from 2021 to 2023.
Dr. van Slyke received his doctorate degree from the University of Toronto.

Former positions of Paul van Slyke

Companies	Position	End
PHARMADRUG INC.	Chief Tech/Sci/R&D Officer	2023-04-30
Sairiyo Therapeutics, Inc. Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures psychedelics drugs for treatment of non-neuropsychiatric conditions	Chief Tech/Sci/R&D Officer	-
Vasomune Therapeutics, Inc. Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops medications for treatment of diseases associated with vascular dysfunction	Chief Tech/Sci/R&D Officer	-

See the detail of Paul van Slyke's experience

Training of Paul van Slyke

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul van Slyke's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
University of Toronto University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vasomune Therapeutics, Inc. Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops medications for treatment of diseases associated with vascular dysfunction	Health Technology
Pharmadrug, Inc. Pharmadrug, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development of cannabis-infused edible products and oil extracts	Health Technology
Sairiyo Therapeutics, Inc. Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures psychedelics drugs for treatment of non-neuropsychiatric conditions	Health Technology